Stocks · News reference
Apogee Enterprises Posts Upbeat Q2 Earnings, Joins Constellation Energy, Freshworks And Other Big Stocks Moving Higher On Tuesday
U.S. stocks rose; Apogee surged 10% on strong results and raised guidance, while Option Care, Ginkgo, PacBio and others posted double-digit gains.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Why Is Astera Labs Stock Surging on Tuesday?
Astera Labs (NASDAQ: ALAB) stock is surging Tuesday amid a broader AI and semiconductor rally. Here’s what’s driving ALAB shares higher.
Marvell Stock Rallies as Investor Day Targets Smash Wall Street Estimates
Marvell investor day lifts fiscal 2028 revenue goal to $20B, the fifth raise in a year, and sets a $70B-$90B 2031 target. MRVL jumps 7%.
Shares of data center infrastructure-related companies are trading higher after Google and Constellation energy announced a 20-year partnership to bring 890 MW of nuclear power online, which helps underpin strong demand for future compute buildout. Also, Baird initiating coverage of Modine Manufacturing with an Outperform rating and a $300 price target further supports the sector.
Apogee Uses Pricing Power, Acquisitions to Outrun Inflation Pressure
Apogee Enterprises (NASDAQ: APOG) stock surged on strong Q2 earnings, beating estimates and raising its fiscal 2027 guidance.
Apogee Enterprises (APOG) Q2 Earnings and Revenues Top Estimates
Apogee Enterprises reported quarterly earnings of $1.17 per share, significantly beating the consensus estimate of $0.59 per share, representing a 98.31% earnings surprise. The company also exceeded revenue expectations with $391.14 million versus the consensus estimate. Despite strong earnings, the stock has underperformed the S&P 500 year-to-date, declining 2.1% versus the market's 13.6% gain. The company holds a Zacks Rank #2 (Buy) rating with favorable estimate revision trends.